ReviewBritish journal of pharmacology2018

Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.

Sevil Korkmaz-Icöz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.